CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Open-label, Randomized Clinical Trial to Evaluate the Safety of Technosphere® Insulin Inhalation Powder in Type 1 or Type 2 Diabetic Subjects With Obstructive Pulmonary Disease (Asthma or Chronic Obstructive Pulmonary Disease) Over a 12 Months Treatment Period With a 2 Month Follow-up

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00642616
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:36.637730+00:00
Published At: 2016-02-15T00:00:00+00:00
Record Updated At: 2017-04-14
Results Posted At: 2016-02-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Type 1 Diabetes Mellitus", "Type 2 Diabetes Mellitus", "Moderate Chronic Obstructive Pulmonary Disease", "Asthma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-04-14"
protocolSection.identificationModule.nctId: "NCT00642616"
protocolSection.identificationModule.officialTitle: "A Phase 3, Open-label, Randomized Clinical Trial to Evaluate the Safety of Technosphere\u00ae Insulin Inhalation Powder in Type 1 or Type 2 Diabetic Subjects With Obstructive Pulmonary Disease (Asthma or Chronic Obstructive Pulmonary Disease) Over a 12 Months Treatment Period With a 2 Month Follow-up"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-02-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.